JadenLindsay personal page - To The Moon

JadenLindsay

No personal profile

7Follow

1Followers

1Topic

0Badge

2022-04-18

$STI ETF(ES3.SI)$time to load

2022-04-16

$STARHILL GLOBAL REIT(P40U.SI)$[Happy]

2022-04-17

$STARHILL GLOBAL REIT(P40U.SI)$[Happy]

2022-04-25

$KEPPEL CORPORATION LIMITED(BN4.SI)$short

2022-05-07

$CapLand IntCom T(C38U.SI)$buy

2022-05-07

Real

Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales

2022-05-02

$FRASERS HOSPITALITY TRUST(ACV.SI)$load

2022-04-21

$FRASERS HOSPITALITY TRUST(ACV.SI)$time to watch list

2022-04-23

$STARHILL GLOBAL REIT(P40U.SI)$not moving

2022-04-20

$SINGAPORE AIRLINES LTD(C6L.SI)$Time to load this

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4112872869043382","uuid":"4112872869043382","gmtCreate":1649918307924,"gmtModify":1649918307924,"name":"JadenLindsay","pinyin":"jadenlindsay","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":7,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9029934562,"gmtCreate":1652712863056,"gmtModify":1676535146879,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/FRLOF\">$FRASERS LOGISTICS &amp; Commercial Trust(FRLOF)$</a>load","listText":"<a href=\"https://ttm.financial/S/FRLOF\">$FRASERS LOGISTICS &amp; Commercial Trust(FRLOF)$</a>load","text":"$FRASERS LOGISTICS & Commercial Trust(FRLOF)$load","images":[{"img":"https://community-static.tradeup.com/news/39d0a089f6148e4c56f2441a307f1cd0","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9029934562","isVote":1,"tweetType":1,"viewCount":2030,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9064419196,"gmtCreate":1652359262515,"gmtModify":1676535084133,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>dropping","listText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>dropping","text":"$FRASERS HOSPITALITY TRUST(ACV.SI)$dropping","images":[{"img":"https://community-static.tradeup.com/news/0137a85480997a893161ea5009158673","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064419196","isVote":1,"tweetType":1,"viewCount":2844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066182356,"gmtCreate":1651878701575,"gmtModify":1676534987357,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>buy","listText":"<a href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>buy","text":"$CapLand IntCom T(C38U.SI)$buy","images":[{"img":"https://community-static.tradeup.com/news/ea851e0f5bb9725b85eb732ca4c988cb","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066182356","isVote":1,"tweetType":1,"viewCount":3649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066188479,"gmtCreate":1651878585691,"gmtModify":1676534987308,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"Real","listText":"Real","text":"Real","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066188479","repostId":"2233574603","repostType":4,"repost":{"id":"2233574603","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1651849786,"share":"https://ttm.financial/m/news/2233574603?lang=en_US&edition=fundamental","pubTime":"2022-05-06 23:09","market":"us","language":"en","title":"Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2233574603","media":"Dow Jones","summary":"The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global ","content":"<html><head></head><body><p>The gene-sequencing supplier <a href=\"https://laohu8.com/S/ILMN\">Illumina</a> delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China&#39;s labs. In calls Thursday, the company reaffirmed its ambitions to increase sales in blood-based cancer screening and new drug discovery.</p><p>Illumina stock plunges 13% in morning trading.</p><p><img src=\"https://static.tigerbbs.com/9616aa4aa5be53cfd87c62a2150db23f\" tg-width=\"838\" tg-height=\"662\" width=\"100%\" height=\"auto\"/></p><p>Illumina&#39;s March quarter sales rose 12% year over year, to $1.22 billion. Sequencing instrument sales of $212 million were up 20%, while consumable sales of $784 million rose 13%. Net profits were $86 million, or 55 cents a share, compared with $147 million, or $1.00. Backing out noncash charges, March 2022 profits were $1.07 a share, compared with $1.89.</p><p>Both sales and earnings beat consensus forecasts.</p><p>&#34;Demand is being driven by a dramatic expansion in reimbursement for the use of genomic testing in cancer therapy selection,&#34; Chief Executive Francis deSouza told Barron&#39;s, late Thursday.</p><p>China&#39;s rolling lockdowns probably deprived Illumina of about $10 million in March quarter sales, said deSouza, and could subtract about 3 percentage points from the 10%-to-12% growth rate that the company had expected for this June quarter. The company believes that China will reopen in the year&#39;s second half, and Illumina reaffirmed its guidance for 14% to16% sales growth this year, with net earnings ranging around $2.43 a share, and cash earnings around $4.10 a share.</p><p>The company&#39;s Grail business had $10 million in March sales of its Galleri blood test, which looks for telltale genetic fragments to give early warning on dozens of different cancers. Grail lost $172 million on March operations. Illumina stuck to its guidance that Grail sales this year can reach $70 million to $90 million. The CEO has said that cancer screening could become the biggest market for sequencing.</p><p>Antitrust regulators in the U.S. and Europe want to unwind Illumina&#39;s $8 billion acquisition of Grail, which the governments believe will stifle competitive efforts in cancer early-detection by rivals like Guardant Health <a href=\"https://laohu8.com/S/GH\">$(GH)$</a> and Exact Sciences <a href=\"https://laohu8.com/S/EXAS\">$(EXAS)$</a>. Their labs rely on Illumina sequencing systems. Illumina is fighting those antitrust cases and says it will appeal any adverse initial rulings.</p><p>In this week&#39;s earnings calls, Illumina discussed another growth initiative in which it is joining with drug developers to expand the use of sequencing in the discovery of new drugs. Psychiatric disorders arise from complex interactions of many genes in the brain, for example, and teasing out treatment targets will require genomic studies of large numbers of people -- and a reduced cost of sequencing that Illumina promises in its future products.</p><p>Thursday, the company announced that it will work with the healthcare-focused investment firm Deerfield Management to use sequencing in Deerfield&#39;s start-up ventures. While Illumina could reap returns from any discovered drugs, deSouza says the real aim is to encourage the biotech industry to use more sequencing systems and consumables.</p><p>Illumina bull Kyle Mikson, at Canaccord Genuity, came away from the sequencer&#39;s earnings results with renewed confidence in his Buy rating. The company&#39;s near term cautions about China&#39;s slowdowns moved Mikson to trim his price target to $520, from $555.</p><p>&#34;[W]e believe core Illumina should continue to outperform expectations in 2022 and beyond,&#34; the analyst wrote in a note Friday.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIllumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-05-06 23:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>The gene-sequencing supplier <a href=\"https://laohu8.com/S/ILMN\">Illumina</a> delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China&#39;s labs. In calls Thursday, the company reaffirmed its ambitions to increase sales in blood-based cancer screening and new drug discovery.</p><p>Illumina stock plunges 13% in morning trading.</p><p><img src=\"https://static.tigerbbs.com/9616aa4aa5be53cfd87c62a2150db23f\" tg-width=\"838\" tg-height=\"662\" width=\"100%\" height=\"auto\"/></p><p>Illumina&#39;s March quarter sales rose 12% year over year, to $1.22 billion. Sequencing instrument sales of $212 million were up 20%, while consumable sales of $784 million rose 13%. Net profits were $86 million, or 55 cents a share, compared with $147 million, or $1.00. Backing out noncash charges, March 2022 profits were $1.07 a share, compared with $1.89.</p><p>Both sales and earnings beat consensus forecasts.</p><p>&#34;Demand is being driven by a dramatic expansion in reimbursement for the use of genomic testing in cancer therapy selection,&#34; Chief Executive Francis deSouza told Barron&#39;s, late Thursday.</p><p>China&#39;s rolling lockdowns probably deprived Illumina of about $10 million in March quarter sales, said deSouza, and could subtract about 3 percentage points from the 10%-to-12% growth rate that the company had expected for this June quarter. The company believes that China will reopen in the year&#39;s second half, and Illumina reaffirmed its guidance for 14% to16% sales growth this year, with net earnings ranging around $2.43 a share, and cash earnings around $4.10 a share.</p><p>The company&#39;s Grail business had $10 million in March sales of its Galleri blood test, which looks for telltale genetic fragments to give early warning on dozens of different cancers. Grail lost $172 million on March operations. Illumina stuck to its guidance that Grail sales this year can reach $70 million to $90 million. The CEO has said that cancer screening could become the biggest market for sequencing.</p><p>Antitrust regulators in the U.S. and Europe want to unwind Illumina&#39;s $8 billion acquisition of Grail, which the governments believe will stifle competitive efforts in cancer early-detection by rivals like Guardant Health <a href=\"https://laohu8.com/S/GH\">$(GH)$</a> and Exact Sciences <a href=\"https://laohu8.com/S/EXAS\">$(EXAS)$</a>. Their labs rely on Illumina sequencing systems. Illumina is fighting those antitrust cases and says it will appeal any adverse initial rulings.</p><p>In this week&#39;s earnings calls, Illumina discussed another growth initiative in which it is joining with drug developers to expand the use of sequencing in the discovery of new drugs. Psychiatric disorders arise from complex interactions of many genes in the brain, for example, and teasing out treatment targets will require genomic studies of large numbers of people -- and a reduced cost of sequencing that Illumina promises in its future products.</p><p>Thursday, the company announced that it will work with the healthcare-focused investment firm Deerfield Management to use sequencing in Deerfield&#39;s start-up ventures. While Illumina could reap returns from any discovered drugs, deSouza says the real aim is to encourage the biotech industry to use more sequencing systems and consumables.</p><p>Illumina bull Kyle Mikson, at Canaccord Genuity, came away from the sequencer&#39;s earnings results with renewed confidence in his Buy rating. The company&#39;s near term cautions about China&#39;s slowdowns moved Mikson to trim his price target to $520, from $555.</p><p>&#34;[W]e believe core Illumina should continue to outperform expectations in 2022 and beyond,&#34; the analyst wrote in a note Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GH":"Guardant Health Inc.","EXAS":"精密科学","ILMN":"Illumina"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2233574603","content_text":"The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China's labs. In calls Thursday, the company reaffirmed its ambitions to increase sales in blood-based cancer screening and new drug discovery.Illumina stock plunges 13% in morning trading.Illumina's March quarter sales rose 12% year over year, to $1.22 billion. Sequencing instrument sales of $212 million were up 20%, while consumable sales of $784 million rose 13%. Net profits were $86 million, or 55 cents a share, compared with $147 million, or $1.00. Backing out noncash charges, March 2022 profits were $1.07 a share, compared with $1.89.Both sales and earnings beat consensus forecasts.\"Demand is being driven by a dramatic expansion in reimbursement for the use of genomic testing in cancer therapy selection,\" Chief Executive Francis deSouza told Barron's, late Thursday.China's rolling lockdowns probably deprived Illumina of about $10 million in March quarter sales, said deSouza, and could subtract about 3 percentage points from the 10%-to-12% growth rate that the company had expected for this June quarter. The company believes that China will reopen in the year's second half, and Illumina reaffirmed its guidance for 14% to16% sales growth this year, with net earnings ranging around $2.43 a share, and cash earnings around $4.10 a share.The company's Grail business had $10 million in March sales of its Galleri blood test, which looks for telltale genetic fragments to give early warning on dozens of different cancers. Grail lost $172 million on March operations. Illumina stuck to its guidance that Grail sales this year can reach $70 million to $90 million. The CEO has said that cancer screening could become the biggest market for sequencing.Antitrust regulators in the U.S. and Europe want to unwind Illumina's $8 billion acquisition of Grail, which the governments believe will stifle competitive efforts in cancer early-detection by rivals like Guardant Health $(GH)$ and Exact Sciences $(EXAS)$. Their labs rely on Illumina sequencing systems. Illumina is fighting those antitrust cases and says it will appeal any adverse initial rulings.In this week's earnings calls, Illumina discussed another growth initiative in which it is joining with drug developers to expand the use of sequencing in the discovery of new drugs. Psychiatric disorders arise from complex interactions of many genes in the brain, for example, and teasing out treatment targets will require genomic studies of large numbers of people -- and a reduced cost of sequencing that Illumina promises in its future products.Thursday, the company announced that it will work with the healthcare-focused investment firm Deerfield Management to use sequencing in Deerfield's start-up ventures. While Illumina could reap returns from any discovered drugs, deSouza says the real aim is to encourage the biotech industry to use more sequencing systems and consumables.Illumina bull Kyle Mikson, at Canaccord Genuity, came away from the sequencer's earnings results with renewed confidence in his Buy rating. The company's near term cautions about China's slowdowns moved Mikson to trim his price target to $520, from $555.\"[W]e believe core Illumina should continue to outperform expectations in 2022 and beyond,\" the analyst wrote in a note Friday.","news_type":1,"symbols_score_info":{"GH":0.9,"ILMN":1,"EXAS":0.9}},"isVote":1,"tweetType":1,"viewCount":2115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9063862377,"gmtCreate":1651453504904,"gmtModify":1676534908080,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>load","listText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>load","text":"$FRASERS HOSPITALITY TRUST(ACV.SI)$load","images":[{"img":"https://community-static.tradeup.com/news/80848a301472dfbd817dfd167d2b80ab","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9063862377","isVote":1,"tweetType":1,"viewCount":2490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9069827874,"gmtCreate":1651277328727,"gmtModify":1676534881432,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/Z74.SI\">$SINGTEL(Z74.SI)$</a>why drop","listText":"<a href=\"https://ttm.financial/S/Z74.SI\">$SINGTEL(Z74.SI)$</a>why drop","text":"$SINGTEL(Z74.SI)$why drop","images":[{"img":"https://community-static.tradeup.com/news/5e0faf4e452e2e69b51cd8c7e8daf001","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9069827874","isVote":1,"tweetType":1,"viewCount":2007,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9060023588,"gmtCreate":1651072064288,"gmtModify":1676534844785,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BN4.SI\">$KEPPEL CORPORATION LIMITED(BN4.SI)$</a>why trading halt","listText":"<a href=\"https://ttm.financial/S/BN4.SI\">$KEPPEL CORPORATION LIMITED(BN4.SI)$</a>why trading halt","text":"$KEPPEL CORPORATION LIMITED(BN4.SI)$why trading halt","images":[{"img":"https://community-static.tradeup.com/news/6a7065163774eb5b2ca8c2c156e5725d","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9060023588","isVote":1,"tweetType":1,"viewCount":1873,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9084488190,"gmtCreate":1650901344715,"gmtModify":1676534812187,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BN4.SI\">$KEPPEL CORPORATION LIMITED(BN4.SI)$</a>short","listText":"<a href=\"https://ttm.financial/S/BN4.SI\">$KEPPEL CORPORATION LIMITED(BN4.SI)$</a>short","text":"$KEPPEL CORPORATION LIMITED(BN4.SI)$short","images":[{"img":"https://community-static.tradeup.com/news/84fef5058e03af4e4fda5526ff53e7ef","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9084488190","isVote":1,"tweetType":1,"viewCount":3287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9084359734,"gmtCreate":1650815192056,"gmtModify":1676534797582,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>short","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>short","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$short","images":[{"img":"https://community-static.tradeup.com/news/33d7ac9c7f3e4367cd78bac1d811419e","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9084359734","isVote":1,"tweetType":1,"viewCount":1915,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9085581990,"gmtCreate":1650727431891,"gmtModify":1676534783166,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>not moving&nbsp;","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>not moving&nbsp;","text":"$STARHILL GLOBAL REIT(P40U.SI)$not moving","images":[{"img":"https://community-static.tradeup.com/news/1e93c15f94379b31ccdfd40ffe725543","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9085581990","isVote":1,"tweetType":1,"viewCount":2221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9086727862,"gmtCreate":1650498796979,"gmtModify":1676534737622,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>time to watch list","listText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>time to watch list","text":"$FRASERS HOSPITALITY TRUST(ACV.SI)$time to watch list","images":[{"img":"https://community-static.tradeup.com/news/dcd864b0a963ff3cce7d6a35947a99a1","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086727862","isVote":1,"tweetType":1,"viewCount":1450,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9086108939,"gmtCreate":1650418790912,"gmtModify":1676534719879,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Time to load this&nbsp;","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Time to load this&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Time to load this","images":[{"img":"https://community-static.tradeup.com/news/09f378b734a46f04e580d4b4d4aed88d","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086108939","isVote":1,"tweetType":1,"viewCount":1044,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9088589161,"gmtCreate":1650363237649,"gmtModify":1676534705437,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"time to load in","listText":"time to load in","text":"time to load in","images":[{"img":"https://community-static.tradeup.com/news/b3be4a5737ce08a086dc58af26fa222b","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9088589161","isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9081286081,"gmtCreate":1650245326200,"gmtModify":1676534677422,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ES3.SI\">$STI ETF(ES3.SI)$</a>time to load","listText":"<a href=\"https://ttm.financial/S/ES3.SI\">$STI ETF(ES3.SI)$</a>time to load","text":"$STI ETF(ES3.SI)$time to load","images":[{"img":"https://community-static.tradeup.com/news/6635d903c047f15ffb80b1d55e8d9c06","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9081286081","isVote":1,"tweetType":1,"viewCount":1041,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9081375253,"gmtCreate":1650205760105,"gmtModify":1676534668472,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","text":"$STARHILL GLOBAL REIT(P40U.SI)$[Happy]","images":[{"img":"https://community-static.tradeup.com/news/4dfca8a9867e7008fccefda477fd7d73","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9081375253","isVote":1,"tweetType":1,"viewCount":1451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9083064675,"gmtCreate":1650058015872,"gmtModify":1676534636138,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","text":"$STARHILL GLOBAL REIT(P40U.SI)$[Happy]","images":[{"img":"https://community-static.tradeup.com/news/4dfca8a9867e7008fccefda477fd7d73","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083064675","isVote":1,"tweetType":1,"viewCount":922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9089380042,"gmtCreate":1649952148493,"gmtModify":1676534614920,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9089380042","repostId":"9089031105","repostType":1,"repost":{"id":9089031105,"gmtCreate":1649930043347,"gmtModify":1676534609136,"author":{"id":"3582798202671514","authorId":"3582798202671514","name":"MP88","avatar":"https://static.tigerbbs.com/98ab4cdb5a6f628d50eef8b5db5303aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582798202671514","idStr":"3582798202671514"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>no worries","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>no worries","text":"$STARHILL GLOBAL REIT(P40U.SI)$no worries","images":[{"img":"https://community-static.tradeup.com/news/f4d8f33e7312202d511bbfde2bcb6171","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9089031105","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9089317390,"gmtCreate":1649952117032,"gmtModify":1676534614905,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9089317390","repostId":"9016476123","repostType":1,"repost":{"id":9016476123,"gmtCreate":1649229403658,"gmtModify":1676534474180,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667667103859","idStr":"3527667667103859"},"themes":[],"title":"🏆【GAME】Hunting Eggs for Extra Saving!","htmlText":"Tiger has prepared some Easter gifts for you, please&nbsp;<a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/easter/\" target=\"_blank\">click&nbsp;here</a>&nbsp;to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien","listText":"Tiger has prepared some Easter gifts for you, please&nbsp;<a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/easter/\" target=\"_blank\">click&nbsp;here</a>&nbsp;to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien","text":"Tiger has prepared some Easter gifts for you, please click here to check them out!Easter can still be a bonus-boosting. Come and find the eggs in our Easter game to open the surprise! Each game contains 3 rounds, the more eggs you catch, the higher the points you can get. Game points can be redeemed for various rewards, including different value stock vouchers worth up to USD 1,000 are waiting for you! Moreover, catching special eggs can get extra points and chances to crack open for some wonderful Easter treats.There are too many hidden surprises to find, oops, the game attempts run out too fast. Don't worry, complete different tasks to earn more game attempts. Also, invite your frien","images":[{"img":"https://community-static.tradeup.com/news/15b435c0d10e0e89ad3e06b7bbd04830","width":"2251","height":"1334"},{"img":"https://community-static.tradeup.com/news/ff9640a9df2f24446e07b7a9b658cb4b","width":"1200","height":"630"},{"img":"https://community-static.tradeup.com/news/795038848b7c7b1d7dda27d92b580946","width":"1656","height":"948"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016476123","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9089905812,"gmtCreate":1649940905590,"gmtModify":1676534611475,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4112872869043382","idStr":"4112872869043382"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9089905812","repostId":"9038658166","repostType":1,"repost":{"id":9038658166,"gmtCreate":1646823700704,"gmtModify":1676534166477,"author":{"id":"3527667668165440","authorId":"3527667668165440","name":"Capital_Insights","avatar":"https://static.tigerbbs.com/cfdc66fff48bb2b9e2d328ac5eb33100","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667668165440","idStr":"3527667668165440"},"themes":[],"title":"🚀Check Top 20 Cash Dividend Stocks' Return By March 2022🔥","htmlText":"$(BLK)$, $(AVGO)$, $(PXD)$,$(CME)$ and $(EQIX)$ are top by cash dividend. Hi，Tigers The current market is under high inflation expectations, the Nasdaq has fallen into bear market territory, and the S&amp;P 500 has also entered a correction range. In such a market environment, we encourage investors to focus on inflation-resistant, fundamentally sound companies and buy stocks at low cost in an environment of relative market risk. <a href=\"https://ttm.financial/TW/9033189036\" target=\"_blank\">🚀🚀Top Investing Opportunities Under War &amp; High Inflation Market</a> <a href=\"https://ttm.financial/TW/9036371111\" target=\"_blank\">3 Charts to Know Companies Prefer Buybacks and Dividends</a> Below are TOP 20 cash dividend companies that have released earnings and announced dividends since Q4 2021. D","listText":"$(BLK)$, $(AVGO)$, $(PXD)$,$(CME)$ and $(EQIX)$ are top by cash dividend. Hi，Tigers The current market is under high inflation expectations, the Nasdaq has fallen into bear market territory, and the S&amp;P 500 has also entered a correction range. In such a market environment, we encourage investors to focus on inflation-resistant, fundamentally sound companies and buy stocks at low cost in an environment of relative market risk. <a href=\"https://ttm.financial/TW/9033189036\" target=\"_blank\">🚀🚀Top Investing Opportunities Under War &amp; High Inflation Market</a> <a href=\"https://ttm.financial/TW/9036371111\" target=\"_blank\">3 Charts to Know Companies Prefer Buybacks and Dividends</a> Below are TOP 20 cash dividend companies that have released earnings and announced dividends since Q4 2021. D","text":"$(BLK)$, $(AVGO)$, $(PXD)$,$(CME)$ and $(EQIX)$ are top by cash dividend. Hi，Tigers The current market is under high inflation expectations, the Nasdaq has fallen into bear market territory, and the S&P 500 has also entered a correction range. In such a market environment, we encourage investors to focus on inflation-resistant, fundamentally sound companies and buy stocks at low cost in an environment of relative market risk. 🚀🚀Top Investing Opportunities Under War & High Inflation Market 3 Charts to Know Companies Prefer Buybacks and Dividends Below are TOP 20 cash dividend companies that have released earnings and announced dividends since Q4 2021. D","images":[{"img":"https://static.tigerbbs.com/dc65f46da7616fedd71d5c0acb8542fc","width":"1181","height":"659"},{"img":"https://static.tigerbbs.com/07dcaecdd6fba84c4430ab0837d3e237","width":"1185","height":"674"},{"img":"https://static.tigerbbs.com/585cd561ef648bdb4698e5c9a9fefcee","width":"1190","height":"672"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9038658166","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9081286081,"gmtCreate":1650245326200,"gmtModify":1676534677422,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ES3.SI\">$STI ETF(ES3.SI)$</a>time to load","listText":"<a href=\"https://ttm.financial/S/ES3.SI\">$STI ETF(ES3.SI)$</a>time to load","text":"$STI ETF(ES3.SI)$time to load","images":[{"img":"https://community-static.tradeup.com/news/6635d903c047f15ffb80b1d55e8d9c06","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9081286081","isVote":1,"tweetType":1,"viewCount":1041,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9083064675,"gmtCreate":1650058015872,"gmtModify":1676534636138,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","text":"$STARHILL GLOBAL REIT(P40U.SI)$[Happy]","images":[{"img":"https://community-static.tradeup.com/news/4dfca8a9867e7008fccefda477fd7d73","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083064675","isVote":1,"tweetType":1,"viewCount":922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9081375253,"gmtCreate":1650205760105,"gmtModify":1676534668472,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>[Happy]&nbsp;","text":"$STARHILL GLOBAL REIT(P40U.SI)$[Happy]","images":[{"img":"https://community-static.tradeup.com/news/4dfca8a9867e7008fccefda477fd7d73","width":"1080","height":"1905"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9081375253","isVote":1,"tweetType":1,"viewCount":1451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9084488190,"gmtCreate":1650901344715,"gmtModify":1676534812187,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BN4.SI\">$KEPPEL CORPORATION LIMITED(BN4.SI)$</a>short","listText":"<a href=\"https://ttm.financial/S/BN4.SI\">$KEPPEL CORPORATION LIMITED(BN4.SI)$</a>short","text":"$KEPPEL CORPORATION LIMITED(BN4.SI)$short","images":[{"img":"https://community-static.tradeup.com/news/84fef5058e03af4e4fda5526ff53e7ef","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9084488190","isVote":1,"tweetType":1,"viewCount":3287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066182356,"gmtCreate":1651878701575,"gmtModify":1676534987357,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>buy","listText":"<a href=\"https://ttm.financial/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>buy","text":"$CapLand IntCom T(C38U.SI)$buy","images":[{"img":"https://community-static.tradeup.com/news/ea851e0f5bb9725b85eb732ca4c988cb","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066182356","isVote":1,"tweetType":1,"viewCount":3649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066188479,"gmtCreate":1651878585691,"gmtModify":1676534987308,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"Real","listText":"Real","text":"Real","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066188479","repostId":"2233574603","repostType":4,"repost":{"id":"2233574603","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1651849786,"share":"https://ttm.financial/m/news/2233574603?lang=en_US&edition=fundamental","pubTime":"2022-05-06 23:09","market":"us","language":"en","title":"Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2233574603","media":"Dow Jones","summary":"The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global ","content":"<html><head></head><body><p>The gene-sequencing supplier <a href=\"https://laohu8.com/S/ILMN\">Illumina</a> delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China&#39;s labs. In calls Thursday, the company reaffirmed its ambitions to increase sales in blood-based cancer screening and new drug discovery.</p><p>Illumina stock plunges 13% in morning trading.</p><p><img src=\"https://static.tigerbbs.com/9616aa4aa5be53cfd87c62a2150db23f\" tg-width=\"838\" tg-height=\"662\" width=\"100%\" height=\"auto\"/></p><p>Illumina&#39;s March quarter sales rose 12% year over year, to $1.22 billion. Sequencing instrument sales of $212 million were up 20%, while consumable sales of $784 million rose 13%. Net profits were $86 million, or 55 cents a share, compared with $147 million, or $1.00. Backing out noncash charges, March 2022 profits were $1.07 a share, compared with $1.89.</p><p>Both sales and earnings beat consensus forecasts.</p><p>&#34;Demand is being driven by a dramatic expansion in reimbursement for the use of genomic testing in cancer therapy selection,&#34; Chief Executive Francis deSouza told Barron&#39;s, late Thursday.</p><p>China&#39;s rolling lockdowns probably deprived Illumina of about $10 million in March quarter sales, said deSouza, and could subtract about 3 percentage points from the 10%-to-12% growth rate that the company had expected for this June quarter. The company believes that China will reopen in the year&#39;s second half, and Illumina reaffirmed its guidance for 14% to16% sales growth this year, with net earnings ranging around $2.43 a share, and cash earnings around $4.10 a share.</p><p>The company&#39;s Grail business had $10 million in March sales of its Galleri blood test, which looks for telltale genetic fragments to give early warning on dozens of different cancers. Grail lost $172 million on March operations. Illumina stuck to its guidance that Grail sales this year can reach $70 million to $90 million. The CEO has said that cancer screening could become the biggest market for sequencing.</p><p>Antitrust regulators in the U.S. and Europe want to unwind Illumina&#39;s $8 billion acquisition of Grail, which the governments believe will stifle competitive efforts in cancer early-detection by rivals like Guardant Health <a href=\"https://laohu8.com/S/GH\">$(GH)$</a> and Exact Sciences <a href=\"https://laohu8.com/S/EXAS\">$(EXAS)$</a>. Their labs rely on Illumina sequencing systems. Illumina is fighting those antitrust cases and says it will appeal any adverse initial rulings.</p><p>In this week&#39;s earnings calls, Illumina discussed another growth initiative in which it is joining with drug developers to expand the use of sequencing in the discovery of new drugs. Psychiatric disorders arise from complex interactions of many genes in the brain, for example, and teasing out treatment targets will require genomic studies of large numbers of people -- and a reduced cost of sequencing that Illumina promises in its future products.</p><p>Thursday, the company announced that it will work with the healthcare-focused investment firm Deerfield Management to use sequencing in Deerfield&#39;s start-up ventures. While Illumina could reap returns from any discovered drugs, deSouza says the real aim is to encourage the biotech industry to use more sequencing systems and consumables.</p><p>Illumina bull Kyle Mikson, at Canaccord Genuity, came away from the sequencer&#39;s earnings results with renewed confidence in his Buy rating. The company&#39;s near term cautions about China&#39;s slowdowns moved Mikson to trim his price target to $520, from $555.</p><p>&#34;[W]e believe core Illumina should continue to outperform expectations in 2022 and beyond,&#34; the analyst wrote in a note Friday.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIllumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-05-06 23:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>The gene-sequencing supplier <a href=\"https://laohu8.com/S/ILMN\">Illumina</a> delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China&#39;s labs. In calls Thursday, the company reaffirmed its ambitions to increase sales in blood-based cancer screening and new drug discovery.</p><p>Illumina stock plunges 13% in morning trading.</p><p><img src=\"https://static.tigerbbs.com/9616aa4aa5be53cfd87c62a2150db23f\" tg-width=\"838\" tg-height=\"662\" width=\"100%\" height=\"auto\"/></p><p>Illumina&#39;s March quarter sales rose 12% year over year, to $1.22 billion. Sequencing instrument sales of $212 million were up 20%, while consumable sales of $784 million rose 13%. Net profits were $86 million, or 55 cents a share, compared with $147 million, or $1.00. Backing out noncash charges, March 2022 profits were $1.07 a share, compared with $1.89.</p><p>Both sales and earnings beat consensus forecasts.</p><p>&#34;Demand is being driven by a dramatic expansion in reimbursement for the use of genomic testing in cancer therapy selection,&#34; Chief Executive Francis deSouza told Barron&#39;s, late Thursday.</p><p>China&#39;s rolling lockdowns probably deprived Illumina of about $10 million in March quarter sales, said deSouza, and could subtract about 3 percentage points from the 10%-to-12% growth rate that the company had expected for this June quarter. The company believes that China will reopen in the year&#39;s second half, and Illumina reaffirmed its guidance for 14% to16% sales growth this year, with net earnings ranging around $2.43 a share, and cash earnings around $4.10 a share.</p><p>The company&#39;s Grail business had $10 million in March sales of its Galleri blood test, which looks for telltale genetic fragments to give early warning on dozens of different cancers. Grail lost $172 million on March operations. Illumina stuck to its guidance that Grail sales this year can reach $70 million to $90 million. The CEO has said that cancer screening could become the biggest market for sequencing.</p><p>Antitrust regulators in the U.S. and Europe want to unwind Illumina&#39;s $8 billion acquisition of Grail, which the governments believe will stifle competitive efforts in cancer early-detection by rivals like Guardant Health <a href=\"https://laohu8.com/S/GH\">$(GH)$</a> and Exact Sciences <a href=\"https://laohu8.com/S/EXAS\">$(EXAS)$</a>. Their labs rely on Illumina sequencing systems. Illumina is fighting those antitrust cases and says it will appeal any adverse initial rulings.</p><p>In this week&#39;s earnings calls, Illumina discussed another growth initiative in which it is joining with drug developers to expand the use of sequencing in the discovery of new drugs. Psychiatric disorders arise from complex interactions of many genes in the brain, for example, and teasing out treatment targets will require genomic studies of large numbers of people -- and a reduced cost of sequencing that Illumina promises in its future products.</p><p>Thursday, the company announced that it will work with the healthcare-focused investment firm Deerfield Management to use sequencing in Deerfield&#39;s start-up ventures. While Illumina could reap returns from any discovered drugs, deSouza says the real aim is to encourage the biotech industry to use more sequencing systems and consumables.</p><p>Illumina bull Kyle Mikson, at Canaccord Genuity, came away from the sequencer&#39;s earnings results with renewed confidence in his Buy rating. The company&#39;s near term cautions about China&#39;s slowdowns moved Mikson to trim his price target to $520, from $555.</p><p>&#34;[W]e believe core Illumina should continue to outperform expectations in 2022 and beyond,&#34; the analyst wrote in a note Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GH":"Guardant Health Inc.","EXAS":"精密科学","ILMN":"Illumina"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2233574603","content_text":"The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China's labs. In calls Thursday, the company reaffirmed its ambitions to increase sales in blood-based cancer screening and new drug discovery.Illumina stock plunges 13% in morning trading.Illumina's March quarter sales rose 12% year over year, to $1.22 billion. Sequencing instrument sales of $212 million were up 20%, while consumable sales of $784 million rose 13%. Net profits were $86 million, or 55 cents a share, compared with $147 million, or $1.00. Backing out noncash charges, March 2022 profits were $1.07 a share, compared with $1.89.Both sales and earnings beat consensus forecasts.\"Demand is being driven by a dramatic expansion in reimbursement for the use of genomic testing in cancer therapy selection,\" Chief Executive Francis deSouza told Barron's, late Thursday.China's rolling lockdowns probably deprived Illumina of about $10 million in March quarter sales, said deSouza, and could subtract about 3 percentage points from the 10%-to-12% growth rate that the company had expected for this June quarter. The company believes that China will reopen in the year's second half, and Illumina reaffirmed its guidance for 14% to16% sales growth this year, with net earnings ranging around $2.43 a share, and cash earnings around $4.10 a share.The company's Grail business had $10 million in March sales of its Galleri blood test, which looks for telltale genetic fragments to give early warning on dozens of different cancers. Grail lost $172 million on March operations. Illumina stuck to its guidance that Grail sales this year can reach $70 million to $90 million. The CEO has said that cancer screening could become the biggest market for sequencing.Antitrust regulators in the U.S. and Europe want to unwind Illumina's $8 billion acquisition of Grail, which the governments believe will stifle competitive efforts in cancer early-detection by rivals like Guardant Health $(GH)$ and Exact Sciences $(EXAS)$. Their labs rely on Illumina sequencing systems. Illumina is fighting those antitrust cases and says it will appeal any adverse initial rulings.In this week's earnings calls, Illumina discussed another growth initiative in which it is joining with drug developers to expand the use of sequencing in the discovery of new drugs. Psychiatric disorders arise from complex interactions of many genes in the brain, for example, and teasing out treatment targets will require genomic studies of large numbers of people -- and a reduced cost of sequencing that Illumina promises in its future products.Thursday, the company announced that it will work with the healthcare-focused investment firm Deerfield Management to use sequencing in Deerfield's start-up ventures. While Illumina could reap returns from any discovered drugs, deSouza says the real aim is to encourage the biotech industry to use more sequencing systems and consumables.Illumina bull Kyle Mikson, at Canaccord Genuity, came away from the sequencer's earnings results with renewed confidence in his Buy rating. The company's near term cautions about China's slowdowns moved Mikson to trim his price target to $520, from $555.\"[W]e believe core Illumina should continue to outperform expectations in 2022 and beyond,\" the analyst wrote in a note Friday.","news_type":1,"symbols_score_info":{"GH":0.9,"ILMN":1,"EXAS":0.9}},"isVote":1,"tweetType":1,"viewCount":2115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9063862377,"gmtCreate":1651453504904,"gmtModify":1676534908080,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>load","listText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>load","text":"$FRASERS HOSPITALITY TRUST(ACV.SI)$load","images":[{"img":"https://community-static.tradeup.com/news/80848a301472dfbd817dfd167d2b80ab","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9063862377","isVote":1,"tweetType":1,"viewCount":2490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9086727862,"gmtCreate":1650498796979,"gmtModify":1676534737622,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>time to watch list","listText":"<a href=\"https://ttm.financial/S/ACV.SI\">$FRASERS HOSPITALITY TRUST(ACV.SI)$</a>time to watch list","text":"$FRASERS HOSPITALITY TRUST(ACV.SI)$time to watch list","images":[{"img":"https://community-static.tradeup.com/news/dcd864b0a963ff3cce7d6a35947a99a1","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086727862","isVote":1,"tweetType":1,"viewCount":1450,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9085581990,"gmtCreate":1650727431891,"gmtModify":1676534783166,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>not moving&nbsp;","listText":"<a href=\"https://ttm.financial/S/P40U.SI\">$STARHILL GLOBAL REIT(P40U.SI)$</a>not moving&nbsp;","text":"$STARHILL GLOBAL REIT(P40U.SI)$not moving","images":[{"img":"https://community-static.tradeup.com/news/1e93c15f94379b31ccdfd40ffe725543","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9085581990","isVote":1,"tweetType":1,"viewCount":2221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9086108939,"gmtCreate":1650418790912,"gmtModify":1676534719879,"author":{"id":"4112872869043382","authorId":"4112872869043382","name":"JadenLindsay","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4112872869043382","authorIdStr":"4112872869043382"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Time to load this&nbsp;","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Time to load this&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Time to load this","images":[{"img":"https://community-static.tradeup.com/news/09f378b734a46f04e580d4b4d4aed88d","width":"1080","height":"2840"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086108939","isVote":1,"tweetType":1,"viewCount":1044,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}